# DAPROCA Pelvic Lymph Node Irradiation to Prostate for High Risk Prostate Cancer: Phase I/II Study

> **NCT01417676** · NA · COMPLETED · sponsor: **University of Aarhus** · enrollment: 87 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** Radiation: pelvic lymph nodes with boost to prostate

## Key facts

- **NCT ID:** NCT01417676
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2019-05
- **Final completion:** 2019-05
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2020-07-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01417676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01417676, "DAPROCA Pelvic Lymph Node Irradiation to Prostate for High Risk Prostate Cancer: Phase I/II Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01417676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*